ClinConnect ClinConnect Logo
Search / Trial NCT06155201

Development and Application of Intelligent Diagnosis and Treatment Norms for Children and Adolescents With Mental Disorders

Launched by CHEN LI · Nov 23, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Intelligence Diagnosis And Treatment System Depressive Disorder Ad Asd Adhd

ClinConnect Summary

This clinical trial is focused on understanding and improving the diagnosis and treatment of mental health disorders in children and adolescents, specifically conditions like depression, anxiety, autism spectrum disorder (ASD), and attention deficit hyperactivity disorder (ADHD). With the increasing number of young people facing these challenges in China, the study aims to gather information about how common these disorders are, where they occur, and the characteristics of the affected children. By including over 12,000 participants under the age of 18, researchers hope to create a database that will help develop better, smarter ways to diagnose and treat these conditions.

To be eligible for this trial, children and teenagers must be diagnosed with depression, anxiety, ASD, or ADHD according to established guidelines and should be able to communicate and understand the study. Those with other serious mental or physical health issues or a history of substance abuse are not eligible. Participants can expect to take part in surveys and assessments that will contribute to a larger effort to create innovative solutions for early detection and treatment of mental health disorders in young people. This project is part of a broader initiative to improve mental health care in the Sichuan and Chongqing areas, utilizing technology to enhance diagnosis and intervention.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Depression patients:(1)Diagnose of depression according to DSM-5;Having the ability to act independently;Clear awareness;Able to communicate normally;Consent to the study ; (2)Under 18 years old;
  • Anxiety patients: (1)Diagnose of anxiety according to DSM-5;Having the ability to act independently;Clear awareness;Able to communicate normally;Consent to the study ; (2)Under 18 years old;
  • ASD patients:(1) Diagnose of ASD according to DSM-5;Do not have other neurological developmental disorders; (2)Under 18 years old;
  • ADHD patients: (1) Diagnose of ADHD according to DSM-5;Do not have other neurological developmental disorders; (2)Aged 4-18 years old;
  • Exclusion Criteria:
  • suffering other mental illnesses and neurological disorders now or in the past
  • suffering severe physical illnesses now or in the past
  • substance or drug abuse now or in the past

About Chen Li

Chen Li is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and adherence to regulatory standards, Chen Li collaborates with leading research institutions and healthcare professionals to design and implement clinical trials that address unmet medical needs. The organization prioritizes patient safety and ethical considerations, fostering an environment of transparency and accountability throughout the research process. Through its initiatives, Chen Li aims to contribute significantly to the development of effective treatments across various therapeutic areas.

Locations

Chongqing, Chongqing, China

Patients applied

0 patients applied

Trial Officials

Li Chen, doctor

Study Director

Children's Hospital of Chongqing Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported